Aldeyra Therapeutics (ALDX) Total Non-Current Liabilities (2013 - 2026)
Aldeyra Therapeutics (ALDX) reported Total Non-Current Liabilities of $3.66 million for Q2 2026, down 84.6% from $23.67 million a year earlier and down 80.1% from the prior quarter.
Powered by 
Analysis
Aldeyra Therapeutics (ALDX) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Aldeyra Therapeutics posted Total Non-Current Liabilities of $21.81 million, down 21.0% from FY2024.
- Total Non-Current Liabilities has a three-year compound annual growth rate of -10.4% (FY2022 to FY2025).
- By year, Total Non-Current Liabilities came in at $27.6 million in FY2024 (+22.5%), $22.53 million in FY2023 (-25.6%) and $30.28 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q2 2014.
- Year over year, Total Non-Current Liabilities has now declined in each of the last five quarters, with an average decline of 20.3% over the last seven quarters.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q4 2024 (growth of 22.5%); the low point was Q2 2026 (a decline of 84.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $18.33 million (Q1 2026), $21.81 million (Q4 2025) and $22.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Aldeyra Therapeutics | 40.82 Mn | -214.61 Mn | - | 3.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Mn |
| Mar 31, 2026 | 18.33 Mn |
| Dec 31, 2025 | 21.81 Mn |
| Sep 30, 2025 | 22.56 Mn |
| Jun 30, 2025 | 23.67 Mn |
| Mar 31, 2025 | 23.60 Mn |
| Dec 31, 2024 | 27.60 Mn |
| Sep 30, 2024 | 32.22 Mn |
| Jun 30, 2024 | 27.73 Mn |
| Mar 31, 2024 | 21.88 Mn |
| Dec 31, 2023 | 22.53 Mn |
| Dec 31, 2022 | 30.28 Mn |
| Jun 30, 2014 | 1.99 Mn |
| Mar 31, 2014 | 42.40 Mn |
| Dec 31, 2013 | 43.71 Mn |
API Access
Aldeyra Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ALDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();